This is a good article on the potential of adult blood stem cells to treat heart disease. I am glad it was reported by Time. But I can’t help gnashing my teeth at the bad science reporting that is epidemic in the mainstream media about embryonic stem cells, to wit: “Unlike other stem-cell therapies, which make use of bone marrow or—more controversially in the U.S.—the blood of human embryos, Fulga believes the procedure patented by TheraVitae is simpler, safer and less invasive. The patient is effectively treating himself with his own blood, so there is very little danger of rejection,” says Fulga, an ophthalmologist. “It’s the safest kind of stem cell you can get.” (My emphasis.)
Yes, adult stem cells are not only safer, embryonic stem cells are unsafe as they often cause tumors, in addition to the rejection issue. But there is no blood in the early embryo. None. This may seem a small point, but there is so much ignorance out there about these issues—unlike this article, some of it sowed intentionally in my view—that it is important to keep the science accurate.
In any event, good for Time for reporting on this adult stem cell story.
Time is short, so I’ll be direct: FIRST THINGS needs you. And we need you by December 31 at 11:59 p.m., when the clock will strike zero. Give now at supportfirstthings.com.
First Things does not hesitate to call out what is bad. Today, there is much to call out. Yet our editors, authors, and readers like you share a greater purpose. And we are guided by a deeper, more enduring hope.
Your gift of $50, $100, or even $250 or more will bring this message of hope to many more people in the new year.
Make your gift now at supportfirstthings.com.
First Things needs you. I’m confident you’ll answer the call.
